Company intelligence / Profile preview

Amplimedical

Muggiò, Monza and Brianza, Italy

Ownership: Private
Employees: ~40
Development stage: Other

Overview

AmpliMedical is an Italian medical device company specializing in the distribution and manufacture of specialized surgical equipment and consumables. Based in Muggiò, Italy, the company focuses on high-tech solutions for neurosurgery, spinal surgery, and orthopedics. Since its acquisition by Medline Industries in 2017, AmpliMedical has integrated its extensive portfolio of surgical products into Medline's global distribution network. The company is known for providing innovative tools such as dural substitutes, spinal implants, and advanced surgical instrumentation to healthcare providers across Europe. It operates as a specialized division, leveraging Medline's logistics while maintaining its expertise in niche surgical markets.

Therapeutic areas: NeurologyOther
Modalities: Device
Industry: Surgical Medical Devices

Beyond the preview

Go deeper on Amplimedical.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Amplimedical.

Explore the full profile